A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Bad weather forced the cancellation of the in-person cycling fundraiser, but participants organized their own bike rides and raised $1.1 million for cancer research and patient care at Columbia.
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
A new study shows that a shift from quiescent to activated liver cells sets the stage for liver cancer and suggests ways to reduce the risk of developing the cancer in people with liver disease.
Though women may know they have dense breasts, many don’t know that having dense breasts comes with a slightly elevated risk of developing breast cancer.
Columbia’s Center for Comprehensive Wellness offers integrative treatments like acupuncture and massage to support cancer patients during their treatment with chemotherapy and radiation.
After skin cancer, prostate cancer is the most common cancer diagnosed among men in the United States, and about one in eight men will be diagnosed with the disease during their lifetime.